Skip to search.
 All Ordinaries Down 2.01%

More On MBLTY

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Mesoblast Limited (MBLTY)

-Other OTC
11.79 Down 0.48(3.91%) 00:22
Add to Portfolio
Prev Close:12.27
Open:11.77
Bid:N/A
Ask:N/A
1y Target Est:37.02
Beta:N/A
Next Earnings Date:N/A
Day's Range:11.77 - 11.79
52wk Range:10.27 - 27.01
Volume:600
Avg Vol (3m):980
Market Cap:786.38M
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):38.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :-1.48
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative therapeutic cell-based products in Australia, the United States, and Singapore. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback